baber/WOPTO huggingface dataset:
Patent JP-H09511522-A (JP)
IPC: C07C69/33
Filed: 1995-03-06
Abstract: A process for preparing polyol fatty acid polyesters having levels of triglyceride below 0.5% is described. Methyl esters having a level of monoglycerides below 500 ppm, a nondetectable level of di- and triglyceride and a glycerine level of less than about 200 ppm are prepared and then used in a two-stage, solvent-free transesterification reaction to prepare the polyol fatty acid polyesters.
Patent JP-H09512742-A (JP)
IPC: B01F5/04
Filed: 1995-05-05
Abstract: In the proposed reaction process, at least two educts (A, B) are divided by their respective assemblies of microchannels (1a, 1b) into spatially separated fluid filaments. These fluid filaments then enter a common mixing and reaction chamber (4). It is essential that the fluid filaments of the two educts (A, B) are allowed to enter the mixing/reaction chamber (4) as free jets (6a, 6b), each free jet (6a) of an educt (A) being led into the mixing/reaction chamber (4) immediately adjacent to a free jet (6b) of a different educt (B). Adjacent free jets then mix by diffusion and/or turbulence. This system significantly accelerates the mixing process by comparison with conventional reactors, and, with rapid chemical reactions, largely prevents the formation of unwanted by-products and secondary products.
Patent JP-2001517302-A (JP)
Title: スキャン型熱顕微鏡法による画像化を用いて化学分析を行う方法および装置
IPC: G01Q30/10
Filed: 1997-12-30
Abstract: (57)【要約】
大気圧にて、大気圧以上で、もしくは、大気圧以下で、または、物質内に沈められたサンプル材料に対し、サンプル材料の表面および表面下のサブミクロン化学分析が行われる。サンプル材料の表面の熱的イメージおよび／または形状的イメージが獲得される。解析用の箇所はイメージを用いて選択される。活性化装置は選択箇所上に位置されると共に、サンプル材料からは、表面および／または表面下生成物が表面削摩され、脱離され、もしくは分解され、分析の為に化学分析器に送られる。
Patent JP-H11504804-A (JP)
IPC: A61K47/48
Filed: 1996-04-26
Abstract: The present invention provides antiviral proteins, peptides and conjugates, as well as methods of obtaining these agents. The antiviral proteins, peptides and conjugates of the present invention can be used alone or in combination with other antiviral agents in compositions, such as pharmaceutical compositions, to inhibit the infectivity, replication and cytopathic effects of a virus, such as a retrovirus, in particular a human immunodeficiency virus, specifically HIV-1 or HIV-2, in the treatment or prevention of viral infection.
Patent JP-H11504377-A (JP)
IPC: C11D3/395
Filed: 1996-04-23
Abstract: Aqueous, acidic bleach laundry detergent compositions with selected chelants which remain substantially undissolved in the acidic product formulation are described. The chelants are chemically stable within the product even upon extended storage and provide improved in-use chelating as well as product performance.
Patent JP-H11506481-A (JP)
Title: 高粘性樹脂作製方法
IPC: C09D11/02
Filed: 1996-04-19
Abstract: (57)【要約】
本明細書は、改善された性質を示す高粘性ゲル化樹脂の作製方法を開示する。望ましい態様においては、樹脂前駆体は、樹脂中に共有架橋結合の形成を誘導する架橋剤、望ましくは熱反応性フェノール樹脂とともに押し出し器に導入され、高剪断条件下での粘性破壊に抵抗性を示す高粘性樹脂を生産する。得られるゲル化インク樹脂はインク作製に直接利用可能であり、さらなるゲル化の必要性をなくし、且つ従来の有機金属性ゲル化剤の使用を回避する。
Patent JP-2000507471-A (JP)
Title: ロッキングブラントカニューレ
IPC: A61M39/02
Filed: 1997-03-03
Abstract: (57)【要約】
開示されているのは、流入液ラインを受けポートに着脱可能に固定することによって、患者に医薬品を安全且つ便利な方法で投与する医療用コネクタ及びその製造方法である。このコネクタは、ハウジングによって画定されたキャビティ内に入り込むカニューレを含む。このハウジングは、コネクタがポートから偶発的に外れるのを防ぐために、保持リッジ及びグリップ部材を含む。
Patent JP-2001515454-A (JP)
Title: アルカリ金属−β−及びβ”−アルミナ及びガリウム酸塩多結晶質セラミック、並びに気相法による製造
IPC: H01M6/18
Filed: 1998-12-31
Abstract: (57)【要約】
α−アルミナをアルカリ金属−β−又はβ”−アルミナに転換させることによって、アルカリ金属−β−又はβ”−アルミナと酸素イオン伝導体とを含有するセラミック複合体が形成される。α−アルミナの連続相及びジルコニアのような酸素イオン伝導性セラミックを含むセラミック複合体がナトリウム又はカリウムの酸化物のようなアルカリ金属酸化物を含有する蒸気にさらされる。アルカリ金属イオンはα−アルミナから転換されたアルカリ金属−β−又はβ”−アルミナを通って、そして酸素イオンは酸素イオン伝導性セラミックを通って反応前面に拡散し、ここでα−アルミナはアルカリ金属−β−又はβ”−アルミナに転換される。アルカリ金属−β”−アルミナに対する安定剤がα−アルミナ／酸素イオン伝導体複合体中に導入され、又はα−アルミナをアルカリ金属−β”−アルミナに転換するのに使用される蒸気中に導入されるのが好ましい。
Patent JP-2000509928-A (JP)
Title: データ通信システムおよび散在エラー検出ビットを用いる方法
IPC: H03M13/29
Filed: 1997-05-01
Abstract: (57)【要約】
エラー検出ビットを発生させて送信されるべきデータビットのシーケンス内に散在させ、送信されるべきメッセージを発生させる、データビットの通信システムおよび通信方法。散在せしめられるデータビットは、データビットに依存してもよく、あるいはデータビットに依存せずに決定されてもよい。送信されるべきメッセージは、畳み込みエンコーディングされ、通信媒体を経て送信される。受信されたメッセージは、エラー表示論理回路に動作上接続された畳み込みデコーダにより畳み込みデコーディングされる。散在せしめられたエラー検出ビットは、伝送中に訂正されなかったエラーを検出するために、または、畳み込みデコーディングを、散在せしめられたエラー検出ビットの確定値に基づいて改善されたエラー訂正動作を行うように制約するために、用いられうる。
Patent JP-2002511911-A (JP)
IPC: F01N3/035
Filed: 1998-04-16
Abstract: Operation of a diesel engine with low particulate emissions is achieved. A diesel engine is equipped with a platinum-catalyzed particulate trap. The engine is operated with a blend of diesel fuel and a fuel-soluble cerium composition to reduce the balance point of the trap with reduced cerium content. Preferably, the fuel will also contain a fuel-soluble organo-platinum group metal compound, or an effective platinum group metal compound can be added to the exhaust or combustion air.
Patent JP-2001515360-A (JP)
IPC: C12N15/09
Filed: 1998-04-16
Abstract: Fusion proteins comprising the TGF-beta Type II receptor linked to a portion of an immunoglobulin constant chain are described. Also described are methods of using the fusion proteins of the invention to treat a variety of fibroproliferative disorders.
Patent JP-2002512544-A (JP)
Title: 非他着性導電性コーティングを備えた電気外科ブレード
IPC: A61B18/14
Filed: 1997-06-04
Abstract: (57)【要約】
導電性で可撓性のセラミックコーティング（１０４）を備えた電気外科ブレード（１００）を提供する。セラミックコーティングは、炭化した組織が堆積しないようにする表面を提供する。これらの性質により、電気外科ブレードは、制御された量の高周波エネルギを組織に送出できる。非晶質チタニウムナイトライドコーティングをステンレス鋼ブレードに付ける製造プロセスにより、コーティングを損傷することなく様々な外科手術を行うために電気外科ブレードを曲げることができる。従って、電気外科ブレードは、切断、凝固、放電療法、及び組織の乾燥を行うために効率的に使用できる。ブレードは主に単極モードで使用されるけれども、本発明は、電気外科ブレードと同じセラミックコーティングを持ち、凝固を行うために双極モードで使用される少なくとも二つの電気外科電極を含む。
Patent MX-150728-A (MX)
Inventor: STOUT JAMES T
IPC: B65D71/00
Filed: 1980-03-28
Abstract: An article carrier for the packaging of multiple articles comprises a bottom (2), side walls (1,11) joined to the side edges of the bottom, end wall panels (7,9,12,13) joined to the end edges of the side walls, a pair of medial partition or riser panels (16,17) joined respectively to the end wall panels at one end of the carrier and extending inwardly therefrom, a pair of riser panels (26,27) foldably joined respectively to the end wall panels at the other end of the carrier and extending inwardly therefrom, a multiple ply handle (49,50,51,52) secured to the medial partition panels and the riser panels, and a locking tab (67) foldably joined to one of the handle panels and disposed intermediate the riser panels.
Patent MX-160599-A (MX)
Inventor: MARLEK EDWARD J
IPC: B29C71/04
Filed: 1984-04-24
Abstract: An improved method for forming closed burstable pouches (10) having breakable seals. The method includes selection of a laminated polymeric film (16) which has two principal layers-an outer layer (20) which is responsive, and an inner layer (18) which is non-responsive, to a radio-frequency (RF) welding field, the outer layer (20) having greater cohesive strength than the remainder of the film and a higher melting pointthan the inner layer (18). With two sheets of such material oriented with their inner surfaces in contact, the breakable seal (14) is formed by applying an RF welding field for a time and at an intensity to heat the outer layers (20) sufficiently to fuse the inner layers (18) by heat transfer from the outer layers without melting the outer layers. In a preferred embodiment, two burstable pouches (10) are made from a double-sized intermediate pouch (26).
Patent NZ-204354-A (NZ)
Title: Multi-channel exploder interrogator
Inventor: SAUNDERS P J
IPC: F42D1/04
Filed: 1983-05-25
Abstract: Detonating apparatus comprises a plurality of multi- channel exploders (MCEs) connected to a control unit which provides an operator/apparatus interface remote from the MCE's detonator circuits. MCEs measure integrity, resonant frequency and impedance at resonance of the detonator circuits connected to each channel, and are thereby programmed to give optimum firing current at the resonant frequency. The control unit provides electrical power, interrogates the MCEs on the status of their detonator circuits, and gives firing signals to be obeyed by MCEs after predetermined delays.
Patent NZ-217489-A (NZ)
Title: Pharmaceutical composition of ace inhibitor and a loop diuretic and the combination product of these two agents
Inventor: BECKER REINHARD
IPC: A61K31/40
Filed: 1986-09-08
Abstract: The preparation contains an angiotensin converting enzyme inhibitor and a loop diuretic.
Patent NZ-218202-A (NZ)
Title: Alkalisation of cocoa in aqueous phase
Inventor: WISSGOTT ULRICH
IPC: A23G1/02
Filed: 1986-11-06
Abstract: For improving the taste and dispersibility of cocoa and for obtaining alkalized cocoa to which is imparted red coloration for obtaining a wide range of colors in shades of red and brown, cocoa meal or liquor and an alkalizing agent in aqueous phase are mixed and heated in an enclosed vessel under a pressure of from above 1 atmosphere to 3 atmospheres at a temperature below 110 DEG  C. without evaporation of water while introducing an oxygen-containing gas into the vessel during at least a part of the mixing and heating for maintaining the excess pressure. After the cocoa is alkalized, water is evaporated from it.
Patent NZ-221141-A (NZ)
Title: Triazolopyridine and traizoloquinoline derivatives, pharmaceutical compositions
Inventor: BRU-MAGNIEZ NICOLE
IPC: A61K31/535
Filed: 1987-07-21
Abstract: The present invention relates to novel compounds corresponding to the formula:   <IMAGE>   in which: n represents an integer between 1 and 8 and optimally 2 or 3; (CH2)n-N can also form a ring or a heterocycle, for example having 5 to 7 atoms and preferably 6 atoms; R1 and R2 can represent hydrogen or a lower alkyl having 1 to 5 carbon atoms or can form, together with the nitrogen, a ring such as pyrrolidine, piperidine, morpholine, thiomorpholine, phenyltetrahydropyridine, piperazine or piperazine N-substituted by an alkyl, a phenyl or a heterocycle; in the case of the phenyltetrahydropyridines and the phenylpiperazines or heteroarylpiperazines, the phenyl or the heterocycle may or may not be substituted by halogens or methoxy, thiomethyl, hydroxyl, nitro, amino, cyano, lower alkyl, trifluoromethyl or trichloromethyl groups; and R3, R4 and R5 can represent hydrogen, a lower alkyl, a hydroxyalkyl or hydroxybenzyl group, a halogen, a trifluoromethyl, a methoxy, a thiomethyl or a nitro or two of them can form a ring, in particular a phenyl in the case of the triazoloquinolines or the triazoloisoquinolines; and the non-toxic acid addition salts. These products are useful as drugs and possess analgesic properties, acting especially on the central nervous system as minor tranquilizers.
Patent NZ-226303-A (NZ)
Title: The process of preparing silica based dough formulations and extrudates; catalyst carriers
Inventor: HUIZINGA TOM
IPC: C01B33/12
Filed: 1988-09-22
Abstract: The invention relates to a process for the preparation of a shapable dough which comprises mixing and kneading a particulate silica with water and with ammonia or an ammonia-releasing compound to obtain a mixture having a total solids content of from 25 to 60% by weight, the ammonia being present in an amount of from 0.5 to 20% by weight on the total solids content of the mixture, to a shapable dough obtained by this process, to the preparation of silica extrudates therefrom and to their use as catalyst carriers in hydrocarbon conversion or hydrocarbon synthesis reactions.
Patent NZ-226582-A (NZ)
Title: Oxazolidinone derivatives; preparatory processes and pharmaceutical compositions
Inventor: GREGORY WALTER ADELMAN
IPC: C07D263/20
Filed: 1988-10-14
Abstract: Aminomethyl oxooxazolidinyl aroylbenzene derivatives, such as  l -N-[3-[4-(2,4-difluorobenzoyl)phenyl]-2-oxooxazolidin-5-ylmethyl]aceta mide, possess useful antibacterial activity.
Patent NZ-231246-A (NZ)
Title: Pharmaceutical compositions comprising fluorine containing pyridone-carboxylic acid derivatives
Inventor: OHTA GENKICHI
IPC: A61K31/44
Filed: 1989-11-02
Abstract: An anti-human immunodeficiency virus composition which comprises a fluorine-containing pyridonecarboxylic acid derivative as an active ingredient and a pharmaceutically acceptable carrier therefor.
Patent NZ-241654-A (NZ)
Title: 2-substituted quinoline derivatives, preparation and pharmaceutical compositions thereof
Inventor: RADDATZ SIEGFRIED
IPC: A61P7/02
Filed: 1992-02-19
Abstract: 2-substituted quinolines of the general formula <IMAGE>   The title compounds are prepared by reacting either the corresponding halomethylquinolines with substituted phenols, then optionally alkylating these and hydrolysing esters to acids, or by reacting phenyl-substituted quinolinecarboxylic acid derivatives with sulphonamides. The novel phenyl-substituted quinolines can be used as active compounds in medicaments, in particular as lipoxygenase inhibitors.
Patent NZ-246655-A (NZ)
Title: Package for carrying cans; plurality of cans held together by inner and outer blanks
Inventor: CAMPBELL GEOFFREY
IPC: B65D75/02
Filed: 1993-01-22
Abstract: PCT No. PCT/GB93/00141 Sec. 371 Date Nov. 7, 1994 Sec. 102(e) Date Nov. 7, 1994 PCT Filed Jan. 22, 1993 PCT Pub. No. WO93/14992 PCT Pub. Date Aug. 5, 1993There is provided a package (10) for a plurality of cans (11). The package incorporates an inner blank (13) which incorporates pairs of arcuate cuts which are pressed over and engage below the can rims. An outer blank (14) is adhered to the inner blank (13) and hinged side panels (25, 27) are wrapped around the cans and the other side panels (26, 28) are adhered to them.
Patent NZ-247133-A (NZ)
Title: Cistern flush mechanism adjustable for different sized cisterns
Inventor: CHELCHOWSKI DAVID
IPC: E03D5/09
Filed: 1993-03-11
Abstract: The present invention discloses an operating mechanism for a cistern (1) or flush tank which is able to be used for a wide variety of cisterns, irrespective of their volume to depth profile. The preferred mechanism takes the form of a generally cup-shaped weir (22) which surrounds the flush valve (18) and from which a support frame (7) extends. The height of the rim of the weir (22) is able to be selected or adjusted, for example by the use of a number of rupturable panels (24) located in the walls of the weir (22). A mechanism (26,27) to adjust for height variations between the flush actuators (14) and the flush operating mechanism (15) is also disclosed.
Patent NZ-250816-A (NZ)
Title: Synthesis of semi-synthetic glycosaminoglycans
Inventor: UNGARELLI FABRIZIO
IPC: C08B37/10
Filed: 1994-02-03
Abstract: A process for the synthesis of semi-synthetic glycosaminoglycans of general formula III <CHEM> is described in which one of the saccharide units characteristic of glycosaminoglycans with heparin or heparan structure, more specifically that of  alpha -L-iduronic-2-O-sulfate acid, has undergone a structural modification, entirely or in part, with transformation into  alpha -L-galacturonic acid substituted in position 3 with nucleophilic radicals of general formula II <CHEM> Said process is carried out by treating glycosaminoglycans with heparin or heparan structure by means of a nucleophilic reagent in alkaline medium.
Patent NZ-251449-A (NZ)
Title: Conjugates adapted for site-specific delivery of an active agent containing a soluble macromolecular proteinaceous pharmaceutical carrier covalently bonded to the active agent
Inventor: FRANSSEN ERIK JOHANNES FRANCIS
IPC: A61K47/48
Filed: 1993-03-15
Abstract: PCT No. PCT/NL93/00061 Sec. 371 Date Nov. 4, 1994 Sec. 102(e) Date Nov. 4, 1994 PCT Filed Mar. 15, 1993 PCT Pub. No. WO93/17713 PCT Pub. Date Sep. 16, 1993Use of  alpha -hydroxy acids and poly- alpha -hydroxy acids as spacer between a therapeutically and/or diagnostically active compound and a soluble macromolecular carrier in pharmaceutical compositions having site-specific delivery. In one embodiment glycolic acid, L-lactic acid or tetra-L-lactic acid is used as spacer between a non-steroidal anti-inflammatory substance and a carrier of low molecular protein (LMWP).
Patent NZ-254237-A (NZ)
Title: Injectable solution of a 2-[(2-pyridyl)methylsulphinyl]-benzimidazole or a salt thereof; an injection kit
Inventor: NAKANISHI SHIGEO
IPC: A61K31/44
Filed: 1993-07-15
Abstract: PCT No. PCT/JP93/00998 Sec. 371 Date Jan. 18, 1995 Sec. 102(e) Date Jan. 18, 1995 PCT Filed Jul. 15, 1993 PCT Pub. No. WO94/02141 PCT Pub. Date Feb. 3, 1994An injection solution comprising a 2-[(2-pyridyl)methylsulfinyl]-benzimidazole compound or a salt thereof having antiulcer activity and an aqueous solvent added with no nonaqueous solvent is disclosed wherein the pH is not less than 9.5 and not more than 11.5.
Patent NZ-260211-A (NZ)
Title: Process for the preparation of 1,2,4-triazine derivatives
Inventor: RAPOLD THOMAS
IPC: B01J25/02
Filed: 1994-03-29
Abstract: The present invention relates to a process for the preparation of aminotriazine derivatives of the formula I <CHEM>  by the solvolysis of compounds of the formula II <CHEM> in the presence of gaseous hydrogen chloride in an alcoholic medium.   The compounds of formula I are useful as intermediates in the manufacture of insecticides.
Patent NZ-264893-A (NZ)
Title: Use of melatonin derivatives for treating desynchronization disorders
Inventor: FLAUGH MICHAEL EDWARD
IPC: C07D209/14
Filed: 1994-11-10
Abstract: The present invention provides a method of treating desynchronization disorders using various melatonin analogs. The invention further provides pharmaceutical formulations suitable for use in such method.
Patent NZ-272976-A (NZ)
Title: Bicyclic oxazole(thiazole)substituted (thio)ethers
Inventor: AICHER THOMAS D
IPC: C07D513/04
Filed: 1995-09-11
Abstract: The invention concerns oxazole and thiazole compounds of formula <CHEM> where the substituents have various significances, in free form or salt form as appropriate. They can be prepared e.g. by coupling or hydrolysis. The compounds can be used as pharmaceuticals, especially as hypoglycemic agents in the treatment of diabetes.
Patent NZ-274585-A (NZ)
Title: Sanitary pantie has frontal elastic strands diverging from crotch
Inventor: JOHANSSON KERSTIN
IPC: A61F13/15
Filed: 1994-10-06
Abstract: The pantie comprising a back-part (2) a front-part (1), an intermediate crotch-part (3) and elastic devices (11 - 14) which extend between the front-part and the back-part of the pantie and function to press an absorbent body (8) permanently mounted or removably attached to the pantie into abutment with the wearer's body. In particular, two of the elastic devices (11, 12) extend from a region (V) in the crotch-part of the pantie to the front-edge of the front pantie-part (1) while diverging relative to one another and extending generally symmetrically in relation to a central line (A - A). Waist and leg elastics 4, 5, 6, 7 are also provided. The absorbent body may comprise primary and secondary absorbents 9 and 10. <IMAGE>
Patent NZ-291602-A (NZ)
Title: Abrasive product of abrasive particles adhered to a base material which is adhered to a backing material
Inventor: KELLY ROBERT G
IPC: B24D13/14
Filed: 1995-08-09
Abstract: Coated abrasive materials can be made from a backing material and abrasive elements which comprise abrasive particles adhered to a rigid base material, said elements being rigidly adhered to the backing material in a predetermined pattern.
Patent NZ-292271-A (NZ)
Title: Triazolopyridazine derivatives, preparation, intermediates and pharmaceutical compositions thereof
Inventor: KAWANO YASUHIKO
IPC: C07D487/04
Filed: 1995-09-11
Abstract: Triazolopyridazine compound of formula (I), wherein R<1> is hydrogen, halogen or alkyl; R<2> is polycarbon alkyl or cycloalkyl; X is oxygen or S(O)p, wherein p is 0 to 2; Y is (i) a group of formula (a) wherein R<3> and R<4> are hydrogen or alkyl, or (ii) cycloalkylene or cycloalkylidene; R<5> and R<6> are H, alkyl, cycloalkyl, or may bind together for form a nitrogen-containing heterocyclic group; m and n are 0 to 4, or a salt thereof, possessing excellent anti-asthmatic, anti-allergic, anti-PAF, eosinophil chemotaxis inhibiting activities.
Patent NZ-298142-A (NZ)
Title: Tcf mutant
Inventor: KINOSAKI MASAHIKO
IPC: C12N15/19
Filed: 1995-12-27
Abstract: The present invention relates to TCF mutant having a novel amino acid sequence which is obtained by mutagenesis of one or more amino acid between N-terminus and the first kringle of the amino acid sequence of native TCF and has lowered affinity to heparin and/or elevated biological activity. The present TCF mutant is prepared by gene manipulation of TCF. The TCF mutants of the present invention have proliferative activity and/or growth stimulative activity in hepatocyte and beneficial as a therapeutic agent for various hepatic diseases and an antitumor agent.
Patent NZ-332296-A (NZ)
Title: method of detecting and diagnosing problems associated with providing a computer service such as access to the internet
Inventor: CASWELL DEBORAH L
IPC: G06F13/00
Filed: 1998-10-13
Abstract: A computer service is modeled by defining a set of services that the computer service depends on and then involves constructing a model of the relationships between the members of the set of services and the computer service.  The services are Internet services such as E-mail, web hosting, web browsing.  The computer service may be that provided by an Internet Service Provider (ISP).  The model allows an ISP, for example, to monitor the speed and responsiveness of the services provided to its users.
Patent NZ-333855-A (NZ)
Title: Detection of psychrotrophic bacillus by the presence of nucleic acid coding for bacillus major cold shock proteins
Inventor: STEWART GORDON SYDNEY ANDERSON
IPC: C12Q1/6823
Filed: 1997-07-24
Abstract: A method for detecting psychrotrophic Bacillus in a sample is described, which method comprises determining whether the sample contains a nucleic acid which codes for a Bacillus major cold shock protein or a major cold protein homologue and which has a conserved nucleotide base which is different in psychrotrophic and mesophilic strains of Bacillus (e.g. B. cereus or B. mycoides). The method is of particular use for detecting the presence of food spoilage organisms in food samples.
Patent NZ-336094-A (NZ)
Title: Use of anti-microtubule agents in medicaments for treating multiple sclerosis
Inventor: HUNTER WILLIAM L
IPC: A61K47/34
Filed: 1997-12-02
Abstract: Anti-microtubule agents such as epothilone A or B, discodermolide, deuterium oxide, hexylene glycol, tubercidin, LY290181, aluminium fluoride, ethylene glycol bis-(succinimidylsuccinate), glycine ethyl ester and paclitaxel, may be used in medicaments to treat multiple sclerosis.  The agent may further comprise a polymer and may be formed into microspheres having an average size between 0.5 and 200mm.
Patent NZ-500674-A (NZ)
Title: Biodegradable polymers chain-extended by phosphates, compositions, articles and methods for making and using the same
Inventor: MAO HAI-QUAN
IPC: C08L77/00
Filed: 1998-04-02
Abstract: Biodegradable polymers are disclosed comprising the recurring monomeric units shown in formula (I) or (II) wherein X is -O- or -NR'-, where R' is H or alkyl; L is a branched or straight chain aliphatic group having from 1-20 carbon atoms; M1 and M2 are each independently (1) a branched or straight chain aliphatic group having from 1-20 carbon atoms; or (2) a branched or straight chain, oxy-, carboxy- or amino-aliphatic group having from 1-20 carbon atoms; Y is -O-, -S- or -NR'-, where R' is H or alkyl; R is H, alkyl, alkoxy, aryl, aryloxy, heterocyclic or heterocycloxy; the molar ratio of x:y is about 1; the molar ratio n:(x or y) is between about 200:1 and 1:200; and the molar ratio q:r is between about 1:99 and 99:1; wherein said biodegradable polymer is biocompatible before and upon biodegradation. Processes for preparing the polymers, compositions containing the polymers and biologically active substances, articles useful for implantation or injection into the body fabricated from the compositions, and methods for controllably releasing biologically active substances using the polymers, are also described.